Goodwill Investors’ Education initiative! Goodwill’s Eagle Eyes!
Watch these counters: Bharti Airtel, RIL, Vodafone idea, SBI, ZEEL, Cadila Healthcare stocks in focus.
Stocks to watch based on market reports:
Bharti Airtel: Reliance Mutual Fund acquired 20 lakh shares of telecom giant Bharti Airtel at an average price of Rs 204.95 per share through bulk deals on the NSE.
Airtel, Vodafone Idea: In what can be seen as a continuation of reforms and burying legacy issues, the government on Tuesday indicated that it is likely to withdraw the case relating to one time spectrum charges (OTSC) amounting to Rs 40,000 crore against the telecom operators. If it does so, the biggest beneficiaries would be Bharti Airtel and Vodafone Idea. The matter does not affect Reliance Jio as the case predates its arrival.
Zee Entertainment Enterprises: The National Company Law Tribunal (NCLT) on Tuesday directed Zee Entertainment Enterprises (ZEEL) to file a reply by October 7 to the petition moved by its foreign investors. The tribunal’s Mumbai bench will hear the case again on Thursday, after ZEEL files its reply.
Srei Infrastructure Finance: The Reserve Bank of India-appointed administrator has taken charge of Srei Infrastructure Finance and its wholly-owned subsidiary Srei Equipment Finance. This happened after the central bank came down heavily on both the companies over governance issues and superseded the boards of directors.
Reliance Industries Ltd: Indian proxy advisory firm Institutional Investor Advisory Services (IiAS) believes the appointment of Yasir Al-Rumayyan, chairman of Saudi oil major Aramco and governor of Saudi sovereign wealth fund, on the board of Reliance Industries (RIL), is a perfect addition to the board. In another development, Morgan Stanley said that RIL is planning to transform its energy business with an over-arching strategy to offer decarbonisation solutions globally at a competitive price in a market potentially worth USD 5 trillion by 2030.
State Bank of India: SBI has moved a plea in the National Company Law Tribunal (NCLT) seeking to initiate insolvency proceedings against Sanjay Singal and Aarti Singal, the erstwhile promoters of Bhushan Power and Steel (BPSL).
Cadila Healthcare: Cadila Healthcare said it has received permission from the Indian drug regulator for conducting phase III trials for its two-dose COVID-19 vaccine ZyCoV-
For uptodate market news please reach www.gwcindia.in daily.
For all your investment needs feel free to reach us.
Give us Missed Call us on 90037 90027 . For Support : 044-40329999